Status:
RECRUITING
Quantitative MRI of Bone Marrow in Patients With Acute Lymphoblastic Leukemia
Lead Sponsor:
Federal Research Institute of Pediatric Hematology, Oncology and Immunology
Conditions:
Acute Leukemia
Eligibility:
All Genders
6-18 years
Phase:
NA
Brief Summary
The study is aimed at assessing changes in the bone marrow of patients from 6 to 18 years old with a diagnosis of acute lymphoblastic leukemia during chemotherapy. Patients of the same age without hem...
Detailed Description
The ratio of fat to water in the bone marrow depends on the cellularity of the bone marrow. In addition to the water/fat ratio in bone marrow there are also other parameters for quantitative MRI asses...
Eligibility Criteria
Inclusion
- patients from 6 to 18 years old
- diagnosis of acute lymphoblastic leukemia during chemotherapy
- patients of the same age without hematological diseases
Exclusion
- patients less then 6, and older then 18 years old
- patients who cannot perform the study MRI without general anesthesia
Key Trial Info
Start Date :
February 22 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 21 2026
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT04767165
Start Date
February 22 2021
End Date
March 21 2026
Last Update
March 8 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Dmitry Rogachev National Research Center of Pediatric Hematology, Oncology and Immunology
Moscow, Russia, 117997